Cigna Corp Q2 2020 Earnings Call Summary - Thomson StreetEvents

Cigna Corp Q2 2020 Earnings Call Summary

Cigna Corp Q2 2020 Earnings Call Summary - Thomson StreetEvents
Cigna Corp Q2 2020 Earnings Call Summary
Published Jul 30, 2020
21 pages (12603 words) — Published Jul 30, 2020
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Brief of CI.N earnings conference call or presentation 30-Jul-20 12:30pm GMT

  
Brief Excerpt:

...A. Note: Uses term labeled adjusted income from operations and EPS on same basis as principal measures of financial performance. 1. B. Overview: Recorded an after-tax special item charge of $99m or $0.27 per share for integration and transaction-related costs. 1. 2. Recorded a special item charge of $11m after-tax or $0.03 per share for cost associated with early extinguishment of debt. 3. Special items are excluded from adjusted income from operations in Co.'s discussion of financial results. 4. Prior year development is now disclosed on a gross basis, consistent with industry practice. Financial supplement includes a roll forward of YTD unpaid medical claims liability for six months ended 06/30/20 and 06/30/19 and for full-year 2019. a. 5. When Co. makes prospective comments regarding financial performance, including full-year 2020 outlook, Co. will do so on a basis that excludes impact of any future share repurchases. 6. Outlook for 2020 assumes a full-year of earnings from Group Disability...

  
Report Type:

Brief

Source:
Thomson StreetEvents
Company:
Cigna Corp
Ticker
CI.N
Time
12:30pm GMT
Format:
PDF Adobe Acrobat
Buy Now

The following is excerpted from the question-and-answer section of the transcript.

(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)

Question: Gary Paul Taylor - JPMorgan Chase & Co, Research Division - Analyst : I have a 2-part question about your MLR expectations and your, I think, relatively appropriate conservatism or caution as we head into the back half. But the question is, as you anticipate higher MLR in the back half, is that explicitly from an expectation around deferred electives coming through? Or around an expectation about higher acuity care being required because of necessary deferred care during the pandemic? And do you have any evidence around those? That's the first part. The second is just given where you stand on your 3-year rolling Commercial MLR minimum positions, if we don't see this pickup in MLR transpire, should we still -- should we assume that in the second half, there's still pretty substantial flow through of MLR to EPS?

Table Of Contents

Cigna Corp at Credit Suisse Healthcare Conference (Virtual) Transcript – 2020-11-09 – US$ 54.00 – Edited Transcript of CI.N presentation 9-Nov-20 5:30pm GMT

Cigna Corp Q3 2020 Earnings Call Summary – 2020-11-05 – US$ 54.00 – Edited Brief of CI.N earnings conference call or presentation 5-Nov-20 1:30pm GMT

Cigna Corp Q3 2020 Earnings Call Transcript – 2020-11-05 – US$ 54.00 – Edited Transcript of CI.N earnings conference call or presentation 5-Nov-20 1:30pm GMT

Cigna Corp at Morgan Stanley Global Healthcare Conference (Virtual) Transcript – 2020-09-16 – US$ 54.00 – Edited Transcript of CI.N presentation 16-Sep-20 12:45pm GMT

Cigna Corp Q2 2020 Earnings Call Transcript – 2020-07-30 – US$ 54.00 – Edited Transcript of CI.N earnings conference call or presentation 30-Jul-20 12:30pm GMT

Cigna Corp at Bank of America Merrill Lynch Healthcare Conference (Virtual) Transcript – 2020-05-12 – US$ 54.00 – Edited Transcript of CI.N presentation 12-May-20 1:40pm GMT

Cigna Corp Q1 2020 Earnings Call Summary – 2020-04-30 – US$ 54.00 – Edited Brief of CI.N earnings conference call or presentation 30-Apr-20 12:30pm GMT

Cigna Corp Q1 2020 Earnings Call Transcript – 2020-04-30 – US$ 54.00 – Edited Transcript of CI.N earnings conference call or presentation 30-Apr-20 12:30pm GMT

Cigna Corp Annual Shareholders Meeting Transcript – 2020-04-22 – US$ 54.00 – Edited Transcript of CI.N shareholder or annual meeting 22-Apr-20 12:00pm GMT

Cigna Corp at Barclays Global Healthcare Conference Transcript – 2020-03-11 – US$ 54.00 – Edited Transcript of CI.N presentation 11-Mar-20 12:00pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Cigna Corp Q2 2020 Earnings Call Summary" Jul 30, 2020. Alacra Store. May 13, 2025. <http://www.alacrastore.com/thomson-streetevents-transcripts/Q2-2020-Cigna-Corp-Earnings-Call-B12789707>
  
APA:
Thomson StreetEvents. (2020). Cigna Corp Q2 2020 Earnings Call Summary Jul 30, 2020. New York, NY: Alacra Store. Retrieved May 13, 2025 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Q2-2020-Cigna-Corp-Earnings-Call-B12789707>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.